Ep. 323 - Agentic AI: From New Targets to the Clinic

AI is bringing sweeping changes to drug development, from how targets are discovered to optimizing clinical trials to maximize an asset’s chance for success. On a special edition of the BioCentury This Week podcast, IQVIA’s Greg Lever joins BioCentury’s analysts to discuss agentic AI’s short- and long-term prospects to help biotechs discover new targets, predict success in preclinical development, and enhance clinical operations. This episode of BioCentury This Week is sponsored by IQVIA Biotech. View full story: https://www.biocentury.com/article/657086 #Biotech #Biopharma #DrugDevelopment #ClinicalTrials #TargetDiscovery #AgenticAI #GraphRAG #DeRisking 00:01 - Sponsor Message: IQVIA Biotech 01:22 - AI in Biotech 05:01 - Machine Learning 06:21 - Generative AI and Language Models 08:37 - Agentic AI 12:43 - AI in Target Discovery 23:44 - AI in Clinical Trial Design To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com. Reach us by sending a text